<SEC-DOCUMENT>0001206774-20-001703.txt : 20200528
<SEC-HEADER>0001206774-20-001703.hdr.sgml : 20200528
<ACCEPTANCE-DATETIME>20200528161520
ACCESSION NUMBER:		0001206774-20-001703
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20200528
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20200528
DATE AS OF CHANGE:		20200528

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			GERON CORP
		CENTRAL INDEX KEY:			0000886744
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				752287752
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-20859
		FILM NUMBER:		20921232

	BUSINESS ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404
		BUSINESS PHONE:		6504737700

	MAIL ADDRESS:	
		STREET 1:		919 EAST HILLSDALE BOULEVARD
		STREET 2:		SUITE 250
		CITY:			FOSTER CITY
		STATE:			CA
		ZIP:			94404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	GERON CORPORATION
		DATE OF NAME CHANGE:	19960521
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>geron3764631-8k.htm
<DESCRIPTION>CURRENT REPORT
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">

<div>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">UNITED STATES<BR></FONT></B><B><FONT size=2 face="Times New Roman">SECURITIES AND EXCHANGE COMMISSION<BR>WASHINGTON, D.C. 20549<BR>______________</FONT></B></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">FORM 8-K</FONT></B></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">CURRENT REPORT<BR></FONT></B><B><FONT size=2 face="Times New Roman">PURSUANT TO SECTION 13 OR 15(d) OF THE<BR>SECURITIES EXCHANGE ACT OF 1934</FONT></B></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">Date of Report (Date of earliest event reported): </FONT><B><FONT size=2 face="Times New Roman">May 28, 2020</FONT></B></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">GERON CORPORATION<BR></FONT></B><FONT size=2 face="Times New Roman">(Exact name of registrant as specified in its charter)</FONT></P>

<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD width="33%" noWrap align=center><B><FONT size=2 face="Times New Roman">Delaware</FONT></B></TD>

   <TD width="1%" noWrap align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD width="33%" noWrap align=center><B><FONT size=2 face="Times New Roman">0-20859</FONT></B></TD>

   <TD width="1%" noWrap align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD width="33%" noWrap align=center><B><FONT size=2 face="Times New Roman">75-2287752</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD width="33%" noWrap align=center><FONT size=2 face="Times New Roman">(State or other jurisdiction of incorporation)</FONT></TD>

   <TD width="1%" noWrap align=center><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="33%" noWrap align=center><FONT size=2 face="Times New Roman">(Commission File Number)</FONT></TD>

   <TD width="1%" noWrap align=center><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="33%" noWrap align=center><FONT size=2 face="Times New Roman">(IRS Employer Identification No.)</FONT></TD></TR></TABLE>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">919 E. HILLSDALE BLVD., SUITE 250<BR>FOSTER CITY, CALIFORNIA 94404<BR></FONT></B><FONT size=2 face="Times New Roman">(Address of principal executive offices, including zip code)</FONT></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">(650) 473-7700<BR></FONT></B><FONT size=2 face="Times New Roman">(Registrant&#8217;s telephone number, including area code)</FONT></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">N/A<BR></FONT></B><FONT size=2 face="Times New Roman">(Former name or former address, if changed since last report)</FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</FONT></P>

<TABLE style="LINE-HEIGHT: normal" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">&#9744;</FONT></TD>

   <TD vAlign=top width="1%">&nbsp;&nbsp;</TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</FONT></TD></TR>

<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD vAlign=top width="1%">&nbsp;</TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>

<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">&#9744;</FONT></TD>

   <TD vAlign=top width="1%"></TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</FONT></TD></TR>

<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD vAlign=top width="1%">&nbsp;</TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>

<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">&#9744;</FONT></TD>

   <TD vAlign=top width="1%"></TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</FONT></TD></TR>

<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD vAlign=top width="1%">&nbsp;</TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman"></FONT></TD></TR>

<TR>

   <TD vAlign=top width="1%"><FONT size=2 face="Times New Roman">&#9744;</FONT></TD>

   <TD vAlign=top width="1%"></TD>

   <TD vAlign=top width="98%"><FONT size=2 face="Times New Roman">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</FONT></TD></TR></TABLE>

<P style="MARGIN-BOTTOM: 4pt; TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Securities registered pursuant to Section 12(b) of the Act:</FONT></P>

<TABLE cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD style="BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid; WIDTH: 33%; WHITE-SPACE: nowrap; BORDER-BOTTOM: #000000 1pt solid; PADDING-BOTTOM: 2pt; TEXT-ALIGN: center; PADDING-TOP: 2pt; PADDING-LEFT: 4pt; BORDER-LEFT: #000000 1pt solid; PADDING-RIGHT: 4pt"><FONT size=2 face="Times New Roman">Title of each class</FONT></TD>

   <TD style="BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid; WIDTH: 33%; WHITE-SPACE: nowrap; BORDER-BOTTOM: #000000 1pt solid; PADDING-BOTTOM: 2pt; TEXT-ALIGN: center; PADDING-TOP: 2pt; PADDING-LEFT: 4pt; PADDING-RIGHT: 4pt"><FONT size=2 face="Times New Roman">Trading Symbol(s)</FONT></TD>

   <TD style="BORDER-TOP: #000000 1pt solid; BORDER-RIGHT: #000000 1pt solid; WIDTH: 33%; WHITE-SPACE: nowrap; BORDER-BOTTOM: #000000 1pt solid; PADDING-BOTTOM: 2pt; TEXT-ALIGN: center; PADDING-TOP: 2pt; PADDING-LEFT: 4pt; PADDING-RIGHT: 4pt"><FONT size=2 face="Times New Roman">Name of each exchange on which registered</FONT></TD></TR>

<TR vAlign=bottom>

   <TD style="BORDER-RIGHT: #000000 1pt solid; WIDTH: 33%; WHITE-SPACE: nowrap; BORDER-BOTTOM: #000000 1pt solid; PADDING-BOTTOM: 2pt; TEXT-ALIGN: center; PADDING-TOP: 2pt; PADDING-LEFT: 4pt; BORDER-LEFT: #000000 1pt solid; PADDING-RIGHT: 4pt"><FONT size=2 face="Times New Roman">Common Stock, $0.001 par value</FONT></TD>

   <TD style="BORDER-RIGHT: #000000 1pt solid; WIDTH: 33%; WHITE-SPACE: nowrap; BORDER-BOTTOM: #000000 1pt solid; PADDING-BOTTOM: 2pt; TEXT-ALIGN: center; PADDING-TOP: 2pt; PADDING-LEFT: 4pt; PADDING-RIGHT: 4pt"><FONT size=2 face="Times New Roman">GERN</FONT></TD>

   <TD style="BORDER-RIGHT: #000000 1pt solid; WIDTH: 33%; WHITE-SPACE: nowrap; BORDER-BOTTOM: #000000 1pt solid; PADDING-BOTTOM: 2pt; TEXT-ALIGN: center; PADDING-TOP: 2pt; PADDING-LEFT: 4pt; PADDING-RIGHT: 4pt"><FONT size=2 face="Times New Roman">The Nasdaq Stock Market LLC</FONT></TD></TR></TABLE>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Emerging growth company &#9744;</FONT><FONT size=2 face=Arial></FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</FONT><FONT size=2 face=Arial></FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Item 2.02 Results of Operations and Financial Condition</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">Geron Corporation (the &#8220;Company&#8221;) is furnishing this information under Item 2.02 of Form 8-K.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">The information in this Current Report, including Exhibit 99.1, is being furnished and shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liabilities of that section. The information in this Current Report, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document filed pursuant to the Securities Act of 1933, as amended, or the Exchange Act.</FONT></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">On May 28, 2020, the Company issued a press release announcing its financial results for the three months ended March 31, 2020. A copy of the press release is attached as Exhibit 99.1.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Item 9.01 Financial Statements and Exhibits</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">(d) Exhibits</FONT></P>

<DIV align=left  STYLE="padding-left: 30pt;">

<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">Exhibit No.</FONT></B></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid">&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD STYLE="width: 96%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">Description</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: center; background-color: rgb(204,238,255)"><A HREF="geron3764631-ex991.htm" STYLE="-sec-extract: exhibit"><FONT size=2 face="Times New Roman">99.1</FONT></A></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: center; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 96%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><A HREF="geron3764631-ex991.htm" STYLE="-sec-extract: exhibit"><FONT size=2 face="Times New Roman">Press release dated May 28, 2020.</FONT></A></TD></TR></TABLE></DIV>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">1</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">SIGNATURE</FONT></B></P>

<P STYLE="text-indent: 15pt; text-align: left"><FONT size=2 face="Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</FONT></P>

<TABLE CELLSPACING="0" CELLPADDING="0" BORDER="0" STYLE="line-height: 14pt; border-collapse: collapse; width: 100%">



<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD COLSPAN="3" STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">GERON CORPORATION</FONT></TD></TR>

<TR>

   <TD COLSPAN="5">&nbsp;</TD></TR>

<TR vAlign=bottom>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Date:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">May 28, 2020</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">By:&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD COLSPAN="2" STYLE="border-bottom: Black 1pt solid; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">/s/ Stephen N. Rosenfield</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left"></TD>

   <TD STYLE="width: 45%; white-space: nowrap; text-align: left"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Name:&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD STYLE="width: 52%; white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Stephen N. Rosenfield</FONT></TD></TR>

<TR vAlign=bottom style="line-height: normal">

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left"></TD>

   <TD STYLE="white-space: nowrap; text-align: left; vertical-align: top"><FONT size=2 face="Times New Roman">Title:</FONT></TD>

   <TD STYLE="white-space: nowrap; text-align: left"><FONT size=2 face="Times New Roman">Executive Vice President, Chief Legal<BR>
Officer and Corporate Secretary</FONT></TD></TR>

</TABLE>


<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">2</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>

</div>

</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>geron3764631-ex991.htm
<DESCRIPTION>PRESS RELEASE DATED MAY 28, 2020
<TEXT>

<HTML>
<HEAD>
   <TITLE></TITLE>
</HEAD>

<BODY bgcolor="#ffffff">



<P style="TEXT-ALIGN: right"><B><FONT size=2 face="Times New Roman">EXHIBIT 99.1</FONT></B></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">Press Release Dated May 28, 2020</FONT></B></P>


<IMG border=0 src="geron3764631-8kx5x1.jpg"> <BR>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">Geron Corporation Reports First Quarter 2020 Financial Results</FONT></B></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">MENLO PARK, Calif., May 28, 2020 </FONT></B><FONT size=2 face="Times New Roman">-- Geron Corporation (Nasdaq: GERN) today reported financial results for the first quarter ended March 31, 2020. The Company will host a conference call today at 4:30 p.m. ET to discuss the recently announced planned Phase 3 clinical trial in refractory MF, as well as an update on the ongoing IMerge Phase 3 clinical trial in lower risk MDS and first quarter financial results.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Financial Resources</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">As of March 31, 2020, Geron had approximately $133 million in cash, cash equivalents, and current and non-current marketable securities. Based on current planning assumptions, the Company estimates these financial resources, combined with the estimated net proceeds of approximately $140 million from the recently closed public offering of securities, provide sufficient funds for the Company&#8217;s operations into the second half of 2022 when top-line results for the IMerge Phase 3 clinical trial in lower risk myelodysplastic syndromes (MDS) are expected, as well completion of patient enrollment for the planned Phase 3 clinical trial in refractory myelofibrosis (MF).</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Revised 2020 Guidance</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">The Company expects its 2020 operating expense burn to range
from $70 to $75 million. This guidance reflects cash conservation measures implemented in April due to the COVID-19 pandemic,
such as suspending travel and postponing a planned imetelstat proof of concept study. It also reflects new costs for startup
activities associated with the planned Phase 3 clinical trial in refractory MF and additional costs for the expansion of
clinical sites for the IMerge Phase 3 clinical trial.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">First Quarter 2020 Results</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">For the first quarter of 2020, the Company reported a net loss of $16.4 million, or $0.08 per share, compared to $10.1 million, or $0.05 per share, for the comparable 2019 period.</FONT></P>
<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Revenues for the first quarter of 2020 were $52,000 compared to $57,000 for the comparable 2019 period. Royalty revenues in 2020 and 2019 primarily reflect estimated royalties from sales of cell-based research products from the Company&#8217;s divested stem cell assets. In connection with the divestiture of Geron&#8217;s human embryonic stem cell assets, including intellectual property and proprietary technology, to Lineage Cell Therapeutics, Inc. (formerly BioTime, Inc., which acquired Asterias Biotherapeutics, Inc.) in 2013, Geron is entitled to receive royalties on future product sales.</FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Total operating expenses for the first quarter of 2020 were $16.9 million compared to $11.4 million for the comparable 2019 period.</FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Research and development expenses for the first quarter of 2020 were $10.8 million compared to $5.9 million for the comparable 2019 period. The increase in research and development expenses, compared to the same period in 2019, primarily reflects higher clinical development costs associated with the IMerge Phase 3 clinical trial and higher personnel-related costs for the additions to the development team in 2019.</FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">General and administrative expenses for the first quarter of 2020 were $6.1 million compared to $5.5 million for the comparable 2019 period. The increase in general and administrative expenses in the first quarter of 2020 compared to same period in 2019 primarily reflects increased personnel-related expenses for additional general and administrative headcount to support growing operational activities.</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Interest and other income for the first quarter of 2020 was $0.8 million compared to $1.2 million for the comparable 2019 period. The decrease in interest and other income for 2020 compared to 2019 primarily reflects lower yields on the Company&#8217;s reduced marketable securities portfolio.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Conference Call</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Geron will host a conference call at 4:30 p.m. ET on Thursday, May 28, 2020 to discuss the planned Phase 3 clinical trial in refractory MF, as well as an update on the ongoing IMerge Phase 3 clinical trial in lower risk MDS and first quarter financial results.</FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Participants may access the conference call live via telephone by dialing domestically +1 (833) 513-0551 or internationally +1 (647) 689-4209. The conference ID is 5582655. A live, listen-only webcast will also be available on the Company&#8217;s website at www.geron.com/investors/events. If you are unable to listen to the live call, an archived webcast will be available on the Company&#8217;s website for 30 days.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">About Imetelstat</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Imetelstat is a novel, first-in-class telomerase inhibitor exclusively owned by Geron and being developed in hematologic myeloid malignancies. Early clinical data suggest imetelstat may have disease-modifying activity through the apoptosis of malignant stem and progenitor cells, which allows potential recovery of normal hematopoiesis. Geron&#8217;s imetelstat development program includes two registration-enabling studies, IMerge, an ongoing Phase 2/3 clinical trial in lower risk myelodysplastic syndromes (MDS), and a planned Phase 3 clinical trial in refractory myelofibrosis (MF) expected to be open for patient screening and enrollment in the first quarter of 2021. Imetelstat has been granted Fast Track designation by the United States Food and Drug Administration for both the treatment of patients with non-del(5q) lower risk MDS who are refractory or resistant to an erythropoiesis-stimulating agent and for patients with Intermediate-2 or High-risk MF whose disease has relapsed after or is refractory to janus kinase (JAK) inhibitor treatment.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">About Geron</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Geron is a late-stage clinical biopharmaceutical company focused on the development and potential commercialization of a first-in-class telomerase inhibitor, imetelstat, in hematologic myeloid malignancies. For more information about Geron, visit www.geron.com.</FONT></P>

<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">Use of Forward-Looking Statements</FONT></B></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Except for the historical information contained herein, this press release contains forward-looking statements made pursuant to the &#8220;safe harbor&#8221; provisions of the Private Securities Litigation Reform Act of 1995. Investors are cautioned that such statements, include, without limitation, those regarding: (i) that the Company estimates its financial resources, combined with the estimated net proceeds of approximately $140 million from the recently closed public offering of securities, provide sufficient funds for the Company&#8217;s operations into the second half of 2022 when top-line results for the IMerge Phase 3 clinical trial in lower risk myelodysplastic syndromes (MDS) are expected, as well completion of patient enrollment for the planned Phase 3 clinical trial in refractory MF; (ii) that the Company expects its 2020 operating expense burn to range from $70 to $75 million; (iii) that the Company has planned a Phase 3 clinical trial in refractory MF and that is expected to be open for patient screening and enrollment in the first quarter of 2021; (iv) that imetelstat may have disease-modifying activity; and (v) other statements that are not historical facts, constitute forward-looking statements. These statements involve risks and uncertainties that can cause actual results to differ materially from those in such forward-looking statements. These risks and uncertainties, include, without limitation, risks and uncertainties related to: (i) whether the COVID pandemic slows or prohibits the Company&#8217;s ability to have top-line results from the IMerge Phase 3 clinical trial in the second half of 2022, the screening and enrollment of patients into the planned Phase 3 clinical trial in refractory MF in the first quarter of 2021 and/or the completion of patient enrollment for the planned Phase 3 clinical trial in refractory MF in the second half of 2022; (ii) whether regulatory authorities permit the further development of imetelstat on a timely basis, or at all, without any clinical holds; (iii) whether imetelstat is safe and efficacious, and whether any future efficacy or safety results may cause the benefit-risk profile of imetelstat to become unacceptable; (iv) the need for future capital; and (v) whether imetelstat demonstrates disease-modifying activity in clinical trials. Additional information on the above risks and uncertainties and additional risks, uncertainties and factors that could cause actual results to differ materially from those in the forward-looking statements are contained in Geron&#8217;s periodic reports filed with the Securities and Exchange Commission under the heading &#8220;Risk Factors,&#8221; including Geron&#8217;s quarterly report on Form 10-Q for the quarter ended March 31, 2020. Undue reliance should not be placed on forward-looking statements, which speak only as of the date they are made, and the facts and assumptions underlying the forward-looking statements may change. Except as required by law, Geron disclaims any obligation to update these forward-looking statements to reflect future information, events or circumstances.</FONT></P>

<HR align=center SIZE=2 width="100%" noShade>



<DIV style="PAGE-BREAK-BEFORE: always"></DIV>



<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">Financial table follows.</FONT></P>

<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">GERON CORPORATION<BR>CONDENSED STATEMENTS OF OPERATIONS</FONT></B></P>

<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR style="LINE-HEIGHT: normal" vAlign=bottom>

   <TD width="88%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD COLSPAN="7" STYLE="padding-bottom: 2pt; width: 11%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">UNAUDITED<BR>Three Months Ended March 31,</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD width="88%" noWrap align=left><I><FONT size=2 face="Times New Roman">(In thousands, except share and per share data)</FONT></I></TD>

   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD COLSPAN="3" STYLE="width: 5%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">2020</FONT></B></TD>

   <TD width="1%" noWrap align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD COLSPAN="3" STYLE="width: 5%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">2019</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Revenues:</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">License fees and royalties</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">52</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">57</FONT></TD>

   <TD width="1%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD width="88%" noWrap align=left>&nbsp;</TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Operating expenses:</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Research and development</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">10,802</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">5,906</FONT></TD>

   <TD width="1%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="background-color: rgb(204,238,255); width: 88%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">General and administrative</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">6,120</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">5,452</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; padding-left: 30pt"><FONT size=2 face="Times New Roman">Total operating expenses</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">16,922</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">11,358</FONT></TD>

   <TD width="1%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Loss from operations</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">(16,870</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">(11,301</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)">&nbsp;</TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD width="88%" noWrap align=left><FONT size=2 face="Times New Roman">Interest and other income</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">754</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">1,162</FONT></TD>

   <TD width="1%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Change in fair value of equity investment</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">(195</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">98</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD width="88%" noWrap align=left><FONT size=2 face="Times New Roman">Other expense</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">(44</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">)</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">(18</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">)</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Net loss</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">(16,355</FONT></TD>

   <TD STYLE="padding-bottom: 1pt; width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">(10,059</FONT></TD>

   <TD STYLE="padding-bottom: 1pt; width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)">&nbsp;</TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><B><FONT size=2 face="Times New Roman"></FONT></B></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD width="88%" noWrap align=left><B><FONT size=2 face="Times New Roman">Basic and diluted net loss per share:</FONT></B></TD>

   <TD width="1%" noWrap align=left><B><FONT size=2 face="Times New Roman"></FONT></B></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="background-color: rgb(204,238,255); width: 88%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Net loss per share</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">(0.08</FONT></TD>

   <TD STYLE="padding-bottom: 1pt; width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">(0.05</FONT></TD>

   <TD STYLE="padding-bottom: 1pt; width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">)</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 88%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Shares used in computing net loss per share</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"></TD>

   <TD STYLE="width: 3%; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">200,222,092</FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD COLSPAN="2" STYLE="width: 4%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;186,393,128</FONT></TD>

   <TD width="1%" noWrap align=left></TD></TR></TABLE>


<P style="TEXT-ALIGN: center"><B><FONT size=2 face="Times New Roman">CONDENSED BALANCE SHEETS</FONT></B></P>

<TABLE style="LINE-HEIGHT: 14pt; BORDER-COLLAPSE: COLLAPSE" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR style="LINE-HEIGHT: normal" vAlign=bottom>

   <TD width="90%" noWrap align=left><I><FONT size=2 face="Times New Roman">(In thousands)</FONT></I></TD>

   <TD width="1%" noWrap align=left>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD COLSPAN="2" STYLE="padding-bottom: 2pt; width: 4%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">March 31,<BR>2020</FONT></B></TD>

   <TD width="1%" noWrap align=center>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</TD>

   <TD COLSPAN="2" STYLE="padding-bottom: 2pt; width: 4%; white-space: nowrap; text-align: center; border-bottom: Black 1pt solid"><B><FONT size=2 face="Times New Roman">December 31,<BR>2019</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD width="90%" noWrap align=left></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="4%" colSpan=2 noWrap align=center><B><FONT size=2 face="Times New Roman">(Unaudited)</FONT></B></TD>

   <TD width="1%" noWrap align=center><B><FONT size=2 face="Times New Roman"></FONT></B></TD>

   <TD width="4%" colSpan=2 noWrap align=center><B><FONT size=2 face="Times New Roman">(Note 1)</FONT></B></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Current assets:</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Cash, cash equivalents and restricted cash</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">20,564</FONT></TD>

   <TD width="1%" noWrap align=right><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">$&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</FONT></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">13,914</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="background-color: rgb(204,238,255); width: 90%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Current marketable securities</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">111,822</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">125,681</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; padding-left: 15pt"><FONT size=2 face="Times New Roman">Other current assets</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">1,769</FONT></TD>

   <TD width="1%" noWrap align=right><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">2,013</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="background-color: rgb(204,238,255); width: 90%; white-space: nowrap; text-align: left; padding-left: 30pt"><FONT size=2 face="Times New Roman">Total current assets</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: center; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">134,155</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">141,608</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="90%" noWrap align=left><FONT size=2 face="Times New Roman">Noncurrent marketable securities</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">1,029</FONT></TD>

   <TD width="1%" noWrap align=right><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">19,651</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Property and equipment, net</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">749</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">408</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="90%" noWrap align=left><FONT size=2 face="Times New Roman">Deposits and other assets</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">6,956</FONT></TD>

   <TD width="1%" noWrap align=right><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">3,850</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">142,889</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">165,517</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">&nbsp;</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="90%" noWrap align=left><FONT size=2 face="Times New Roman">Current liabilities</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">16,916</FONT></TD>

   <TD width="1%" noWrap align=right><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD width="3%" noWrap align=right><FONT size=2 face="Times New Roman">28,162</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">Noncurrent liabilities</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">5,159</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman">2,200</FONT></TD></TR>

<TR vAlign=bottom>

   <TD width="90%" noWrap align=left><FONT size=2 face="Times New Roman">Stockholders&#8217; equity</FONT></TD>

   <TD width="1%" noWrap align=left><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">120,814</FONT></TD>

   <TD width="1%" noWrap align=right><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 1pt solid"></TD>

   <TD STYLE="width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 1pt solid"><FONT size=2 face="Times New Roman">135,155</FONT></TD></TR>

<TR vAlign=bottom>

   <TD STYLE="width: 90%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: left; background-color: rgb(204,238,255)"></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">142,889</FONT></TD>

   <TD STYLE="width: 1%; white-space: nowrap; text-align: right; background-color: rgb(204,238,255)"><FONT size=2 face="Times New Roman"></FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 1%; white-space: nowrap; text-align: left; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">$</FONT></TD>

   <TD STYLE="background-color: rgb(204,238,255); width: 3%; white-space: nowrap; text-align: right; border-bottom: Black 2pt double"><FONT size=2 face="Times New Roman">165,517</FONT></TD></TR></TABLE>

<BR>

<TABLE style="LINE-HEIGHT: normal" cellSpacing=0 cellPadding=0 width="100%" border=0>



<TR vAlign=bottom>

   <TD vAlign=top width="1%" noWrap align=left><B><FONT size=2 face="Times New Roman">Note 1</FONT></B><FONT size=2 face="Times New Roman">:&nbsp;</FONT></TD>

   <TD vAlign=top width="99%" align=left><FONT size=2 face="Times New Roman">Derived from audited financial statements included in the Company&#8217;s annual report on Form 10-K for the year ended December 31, 2019.</FONT></TD></TR></TABLE>


<P style="TEXT-ALIGN: left"><B><FONT size=2 face="Times New Roman">CONTACT:<BR></FONT></B><FONT size=2 face="Times New Roman">Suzanne Messere<BR></FONT><FONT size=2 face="Times New Roman">Investor and Media Relations<BR>investor@geron.com <BR>media@geron.com </FONT></P>

<P style="TEXT-ALIGN: left"><FONT size=2 face="Times New Roman">CG Capital<BR>877-889-1972</FONT></P>

<P style="TEXT-ALIGN: center"><FONT size=2 face="Times New Roman">###</FONT></P>

<HR align=center width="100%" noShade size="2">



</BODY>

</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>geron3764631-8kx5x1.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 geron3764631-8kx5x1.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  $! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_
MVP!# 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0$!
M 0$! 0$! 0$! 0$! 0$! 0$! 0$! 0'_P  1"  Q & # 2(  A$! Q$!_\0
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MU=;7V-G:XN/DY>;GZ.GJ\O/T]?;W^/GZ_]H # ,!  (1 Q$ /P#[8_X+??\
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M!/Q-X6\.FY\7?$#P]806^H>(+VX@MH+:ZO$\^^GBM;1'=U4_H;_P>9?\HF?
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MT.ROK.ZB6:VN[2ZT&U@N;:XAD#1S03PR/%+&ZLDD;LC @D5_#OXO_P""'?\
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K+K,MI;7%W:V4DVH0?T744 %%%% !1110 4444 %%%% !1110 4444 ?_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
